MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.620
+0.030 (1.89%)
At close: Apr 28, 2026, 4:00 PM EDT
1.551
-0.069 (-4.23%)
After-hours: Apr 28, 2026, 5:47 PM EDT
MetaVia Employees
MetaVia had 8 employees as of December 31, 2025. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,621,625
Market Cap
8.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| Processa Pharmaceuticals | 12 |
| TransCode Therapeutics | 12 |
| NuCana | 12 |
| Indaptus Therapeutics | 5 |
| Creative Medical Technology Holdings | 4 |
| Silo Pharma | 3 |
| PharmaCyte Biotech | 2 |
MTVA News
- 18 days ago - MetaVia Doses the First Patient in Higher-Dose Phase 1 Study of DA-1726, Its GLP-1 and Glucagon Dual Agonist for the Treatment of Obesity - PRNewsWire
- 4 weeks ago - MetaVia Reports Year End 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 5 weeks ago - MetaVia Advances GLP-1-Based Obesity Program with IRB Approval for Higher-Dose Phase 1 Studies of DA-1726, a GLP-1 and Glucagon Dual Agonist Demonstrating Best-in-Class Potential for Weight Loss and Glucose Control - PRNewsWire
- 6 weeks ago - MetaVia Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 6 weeks ago - MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035 - PRNewsWire
- 7 weeks ago - MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum - PRNewsWire
- 2 months ago - MetaVia Transcript: Emerging Growth Virtual Conference - Transcripts
- 2 months ago - MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference - PRNewsWire